MedMountain Ventures, a Salt Lake City, UT-based seed-stage venture capital firm, held the first close of MMVII, its second fund.
Founded in 2018 and led by Managing Partners Branden Rosenhan, MD, Saumitra Thakur, MD, and General Partner and COO Katelin Roberts, MMV is a seed-stage healthcare venture capital which focuses on medical device, diagnostic, and digital health companies that can scale and create value while being capital-efficient.
The firm has a special interest in emerging venture cities, particularly the Mountain West. Its portfolio is diverse in sector and geography, but also in its founder base.
MMVII has already made its initial investments into:
- Options MD, an AI-powered platform that connects patients with treatment-resistant depression to clinics that can offer advanced therapies, and
- and Ceresti Health, which identifies patients with dementia most at risk for adverse outcomes and up-skills their caregivers to prevent hospitalizations.